Osteonecrosis (Avascular Necrosis) Treatment in Germany

Osteonecrosis (avascular necrosis — AVN) is bone tissue death due to disrupted blood supply. The femoral head is most commonly affected (70%), followed by the knee, shoulder, scaphoid, and talus. Without treatment, osteonecrosis leads to articular surface collapse and severe arthrosis. Treatment in Germany includes early MRI diagnosis, innovative MIBRAR® therapy for bone regeneration, and when necessary — surgical methods from decompression to joint replacement.

What is Osteonecrosis

Bone tissue is a living structure requiring constant blood supply. When blood flow is disrupted, osteocytes (bone cells) die within 6–12 hours. Necrotic bone loses strength and "collapses" under loading — articular surface collapse occurs, triggering irreversible joint destruction. High-risk zones have "end-type" blood supply without collaterals: the femoral head (fed by arteries within the joint capsule — disrupted by femoral neck fracture or dislocation), proximal scaphoid pole (retrograde blood supply — fractures often cause necrosis), talus (60% articular surface, minimal vascular entries), and femoral/tibial condyles (spontaneous knee osteonecrosis — SPONK).

Causes

Trauma from femoral neck fracture, hip dislocation, or scaphoid fracture mechanically damages vessels. Corticosteroids (>20 mg prednisone >3 months) are the second most common cause through fat embolism of intraosseous vessels. Chronic alcohol abuse causes fatty bone marrow infiltration. Systemic diseases include sickle cell disease, systemic lupus erythematosus, and antiphospholipid syndrome. Radiation therapy damages vessels. Idiopathic cases (20–30%) have no identified cause. Decompression sickness in divers involves gas embolism.

ARCO Stages

Key point: at stages I–II, MIBRAR® can prevent collapse and preserve the native joint. At stages III–IV, joint replacement is often necessary.

Symptoms

Deep, aching pain in the affected joint area is typical — for femoral head osteonecrosis, groin pain with knee radiation (!). Limited motion develops with internal rotation affected first (hip). Loading-related limping worsens progressively. Sharp pain intensification occurs with collapse (stage III) — an "acute episode." The condition is insidious — at stages I–II symptoms may be minimal while the pathological process is active. Early diagnosis is critical.

Diagnosis

MRI is the gold standard with 99% sensitivity, detecting osteonecrosis at stage I when X-rays are still normal. The characteristic "double line" sign (hypointense rim with hyperintense inner zone on T2) is pathognomonic. Radiography shows changes from stage II with "crescent sign" at stage III. CT details subchondral fractures for surgical planning. Scintigraphy identifies multiple foci (up to 50% of corticosteroid patients have bilateral osteonecrosis). Laboratory tests include lipid profile, coagulation factors (thrombophilia), and serology (SLE).

Conservative Treatment

Effective only at early stages and as adjunct therapy. Protected weight bearing with crutches limits loading on the affected joint. Bisphosphonates slow necrotic bone resorption and may delay collapse. Anticoagulants address thrombophilia. Statins improve microcirculation in steroid-induced osteonecrosis. Corticosteroid dose reduction is implemented when possible.

MIBRAR® Therapy

Osteonecrosis (Osteonekrosen) is included in the indications for MIBRAR® technology, particularly effective at stages I–II when the articular surface hasn't collapsed.

MIBRAR® achieves decompression using a spinal probe (0.8 mm) penetrating the necrosis zone to reduce intraosseous pressure and improve blood inflow. Targeted microperforations create channels for new vessel ingrowth (revascularization). ARC transplantation delivers autologous regenerative concentrate (mesenchymal stem cells + growth factors) directly into the necrosis zone where stem cells differentiate into osteoblasts and initiate new bone formation.

Advantages over standard core decompression: standard decompression uses an 8–10 mm drill causing significant bone trauma versus MIBRAR®'s 0.8 mm probe; standard decompression delivers no stem cells versus targeted ARC transplantation; MIBRAR® is outpatient without anesthesia versus inpatient with anesthesia; MIBRAR® can treat multiple joints simultaneously for multifocal osteonecrosis. MRI follow-up at 3–6 months confirms bone structure restoration and collapse prevention per Prof. Babayan's data.

Surgical Treatment

Core decompression drills a channel into the necrosis zone to reduce pressure and stimulate revascularization at stages I–II with 60–80% success. Core decompression plus bone grafting fills the channel with autograft or bone substitute. Vascularized bone graft transplants a fibula on a vascular pedicle into the femoral head for young patients at stages II–III. Rotational osteotomy moves healthy bone into the weight-bearing zone. Joint replacement at stages III–IV uses artificial joint substitution — in Germany with ceramic bearing couples providing minimal wear and 25–30 year longevity.

Treatment Costs

All treatment prices in Germany.

Advantages of Osteonecrosis Treatment in Germany

Germany offers early MRI detection before collapse, MIBRAR® therapy for stem cell bone regeneration and collapse prevention, minimally invasive decompression with a 0.8 mm probe (vs. 10 mm drill), ceramic-bearing joint replacement for late stages, full rehabilitation at world-class clinics, and multilingual assistance. Osteonecrosis is a race against time — the earlier the diagnosis and treatment, the higher the chance of preserving the native joint. Contact us for the optimal program at the best clinics in Germany.